Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146911

Pw146911 View Pathway
drug action

Ubrogepant Drug Metabolism Action Pathway

Homo sapiens

PW176296

Pw176296 View Pathway
metabolic

Ubrogepant Predicted Metabolism Pathway

Homo sapiens
Metabolites of Ubrogepant are predicted with biotransformer.

PW145696

Pw145696 View Pathway
drug action

Udenafil Drug Metabolism Action Pathway

Homo sapiens

PW176414

Pw176414 View Pathway
metabolic

Udenafil Predicted Metabolism Pathway

Homo sapiens
Metabolites of Udenafil are predicted with biotransformer.

PW124408

Pw124408 View Pathway
metabolic

UDP-N-acetyl-D-Glucosamine

Pseudomonas aeruginosa

PW244655

Pw244655 View Pathway
metabolic

Uliana1

Saccharomyces cerevisiae

PW145857

Pw145857 View Pathway
drug action

Ulipristal Drug Metabolism Action Pathway

Homo sapiens

PW176158

Pw176158 View Pathway
metabolic

Ulipristal Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Ulipristal are predicted with biotransformer.

PW127826

Pw127826 View Pathway
drug action

Ulobetasol Action Pathway

Homo sapiens
Ulobetasol, also known as Halobetasol, is a highly potent corticosteroid used to treat corticosteroid-responsive dermatoses. This drug is available as a topical cream, foam, spray, or ointment. Ulobetasol is a glucocorticoid receptor agonist and is structurally related to clobetasol. By binding to the glucocorticoid receptor, it influences transcription factors AP-1 and NF-kB to block the transcription of COX-2/prostaglandin G/H synthase 2 which reduces the amount of prostanoids being produced from arachidonic acid. Prostanoids such as PGI2 and thromboxane A2 influence the effects of inflammation through vasoconstriction/dilation, pain sensitivity, and platelet aggregation. This drug also affects the promoter of annexin-1, an important inflammatory protein as it affects leukocytes and blocks phospholipase A2 which reduces the amount of arachidonic acid being cleaved from the phospholipid bilayer. Reducing the amount of arachidonic acid formed further decreases the concentrations of prostanoids mentioned calming inflammation. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.

PW144712

Pw144712 View Pathway
drug action

Ulobetasol Drug Metabolism Action Pathway

Homo sapiens